43 Chapter 2 References 1. Steiner RD, Adsit J, Basel D. COL1A1/2 Osteogenesis Imperfecta. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® (Internet). Seattle (WA): University of Washington, Seattle; 2005. p. 1993–2019. 2. Van Dijk FSS, DOO S. Osteogenesis imperfecta: clinical diagnosis,nomenclature and severity assessment. Am J Med Genet A. 2014; 164(6):1470–81. 3. Starr SR, Roberts TT, Fischer PR. Osteogenesis imperfecta: primarycare. Pediatr Rev. 2010;31(8):e54–64. 4. Vander Zee K, Sanderman R, Heyink JW, de Haes H. Psychometricqualities of the RAND 36-item Health Survey 1.0: a multidimensional measure of general health status. Int J Behav Med. 1996;3:104–22. 5. Aaronson NK, Muller M, Cohen PDA, et al. Translation, validation, andnorming of the Dutch language version of the SF-36 health survey in community and chronic disease populations. J Clin Epidemiol. 1998; 51(11):1055–68. 6. Tarlov AR, Ware JE, Greenfield S, Nelson EC, Perrin E, Zubkoff M. The medical outcomes study: an application of methods for monitoring the results of medical care. JAMA. 1989;262(7):925–30. 7. Ware JE, Kosinski M, Keller SD. SF-36 Physical and mental health summary scales: a user’s manual. Boston, MA: Health Institute, New England Medical Center; 1994. 8. Ware JE, Kosinski M, Bayliss MS, McHorney CA, Rogers WH, Raczek A.Comparison of methods for the scoring and statistical analysis of SF36 health profile and summary measures: summary of results from the medical outcomes study. Med Care. 1995;33(4 Suppl):AS264–79. 9. Mc Horney CA, Ware JE Jr, Raczek AE. The MOS 36-item short-formhealth survey (sf-36): II. Psychometric and clinical tests of validity in measuring physical and mental health constructs. Med Care. 1993; 31(3):247–63. 10. Jenkinson C, Wright L, Coulter A. Criterion validity and reliability ofthe SF-36 in a population sample. Qual Life Res. 1994;3(1):7–12. 11. Zee KI, Sanderman R, Heyink JW, Haes H. Psychometric qualities ofthe rand 36-item health survey 1.0: a multidimensional measure of general health status. Int J Behav Med. 1996;3(2):104–22. 12. Schmider E, Ziegler M, Danay E, Beyer L, Bühner M. Is it really robust?: reinvestigating the robustness of ANOVA against violations of the normal distribution assumption. Methodology. 2010;6(4):147–51.
RkJQdWJsaXNoZXIy MTk4NDMw